Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
28.61
+0.25 (0.88%)
At close: Jul 8, 2025, 4:00 PM
28.61
0.00 (0.00%)
After-hours: Jul 8, 2025, 4:15 PM EDT

HRTS Holdings Information

HRTS is an equity ETF with a total of 48 individual holdings. The top holdings are Eli Lilly and Company stock at 9.76%, Abbott Laboratories at 4.54%, Novo Nordisk at 4.46%, Roche Holding AG at 4.17%, and AstraZeneca at 4.09%.

Total Holdings
48
Top 10 Percentage
44.58%
Asset Class
Equity
ETF Category
Health
Assets
51.23M
PE Ratio
22.06

Sector Allocation

Top 25 Holdings

Jul 2, 2025
No.SymbolName WeightShares
1LLYEli Lilly and Company9.76%6,409
2ABTAbbott Laboratories4.54%17,321
3CPH: NOVO.BNovo Nordisk A/S4.46%32,699
4RHHBYRoche Holding AG4.17%51,834
5LON: AZNAstraZeneca PLC4.09%14,781
6BBIOBridgeBio Pharma, Inc.3.84%45,855
7UNHUnitedHealth Group Incorporated3.65%6,069
8BSXBoston Scientific Corporation3.49%17,217
9SWX: NOVNNovartis AG3.33%13,706
10VRTXVertex Pharmaceuticals Incorporated3.24%3,623
11GILDGilead Sciences, Inc.3.16%14,514
12MDTMedtronic plc3.02%17,514
13TMOThermo Fisher Scientific Inc.2.68%3,209
14AMGNAmgen Inc.2.60%4,480
15CRNXCrinetics Pharmaceuticals, Inc.2.59%45,035
16MRKMerck & Co., Inc.2.53%15,691
17ABBVAbbVie Inc.2.26%6,061
18TYO: 4519Chugai Pharmaceutical Co., Ltd.2.25%23,221
19EWEdwards Lifesciences Corporation2.17%14,383
20ALNYAlnylam Pharmaceuticals, Inc.2.14%3,319
21PODDInsulet Corporation2.12%3,594
22BMYBristol-Myers Squibb Company2.08%22,314
23REGNRegeneron Pharmaceuticals, Inc.2.08%1,938
24DHRDanaher Corporation2.05%5,181
25MCKMcKesson Corporation1.91%1,385
As of Jul 2, 2025
Showing 25 of 48
Subscribe to see the full list